Skip to main content
Uqba Khan, MD, Oncology, Brooklyn, NY

Uqba Khan MD

Gastrointestinal Cancer, Hematologic Oncology


Assistant Professor Weill Cornell Medicine

Request Appointment
  • 501 6th StBrooklyn, NY 11215

  • Book by Phone+1(831) 531-6823

Overview of  Dr. Khan

Dr. Uqba Khan is an oncology specialist based in Brooklyn, NY, with subspecialties in gastrointestinal cancer and hematologic oncology. He completed his internal medicine residency at St. Agnes HealthCare and advanced GI oncology fellowship at New York Presbyterian Hospital. He currently serves as an Assistant Professor at NewYork-Presbyterian Brooklyn Methodist Hospital and Weill Cornell Medicine. Dr. Khan has expertise in managing cancers like gastrointestinal cancer, hepatocellular carcinoma, and gastric cancer. He has contributed several publications in leading medical journals and is recognized with awards from organizations like the American Society of Clinical Oncology. Additionally, he is involved in clinical trials related to metastatic or unresectable gastroesophageal cancers.

Education & Training

  • New York Presbyterian Hospital
    New York Presbyterian HospitalFellowship, Advanced GI Oncology, 2018 - 2019
  • St Agnes HealthCare
    St Agnes HealthCareResidency, Internal Medicine, 2012 - 2015
  • Allama Iqbal Medical College
    Allama Iqbal Medical CollegeClass of 2008

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2018 - 2027
  • MI State Medical License
    MI State Medical License 2015 - 2018

Awards, Honors, & Recognition

  • New York Rising Stars 2020 Super Doctors, 2020
  • Merit Award American Society of Ccliniccal Oncology, 2018

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Phase II study of a telomerase-specific oncolytic adenovirus (OBP-301, Telomelysin) in combination with pembrolizumab in gastric and gastroesophageal junction adenocar... 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Antibiotics May Blunt Cancer Immunotherapy Response
    Antibiotics May Blunt Cancer Immunotherapy ResponseMay 14th, 2019

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: